Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3 Pt 2
pubmed:dateCreated
1995-4-27
pubmed:abstractText
Angiotensin II (ANG II) induces vascular smooth muscle contraction and functions as a growth factor stimulating vascular smooth muscle cell (VSMC) hypertrophy. We wondered whether ANG II might induce expression of alpha 1-adrenergic receptors (ARs) in cultured VSMCs, which would then potentially accentuate the effects of catecholamines in the cells. Rat VSMCs were preincubated with phenoxybenzamine to inactivate alpha 1-ARs; the cells were then treated with ANG II for 24 h. ANG II-treated cells expressed an increased number of alpha 1-ARs compared with controls, suggesting that ANG II increased the rate of alpha 1-AR synthesis. ANG II markedly induced accumulation of alpha 1A/D- and alpha 1B-AR mRNAs in a concentration- and time-dependent manner. This effect of ANG II was blocked by the specific ANG II-receptor agonist [Sar1-Ile8]ANG II. ANG II-induced accumulation of alpha 1A/D-AR mRNAs was completely abolished by transcriptional inhibitor actinomycin D. ANG II markedly increased the transcriptional rate of the alpha 1A/D-AR gene without changing stability of alpha 1A/D-AR mRNAs. Protein kinase C (PKC) activator 4 beta-phorbol 12-myristate 13-acetate also induced accumulation of alpha 1A/D-AR mRNAs, and PKC inhibitor H-7 completely blocked ANG II-induced accumulation of the alpha 1A/D-AR mRNAs. Neither the biologically inactive ANG II analogue des-Phe8-ANG II nor the calcium ionophores A-23187 and BAY K-8466 induced alpha 1A/D-AR mRNAs. Finally, ANG II preincubation increased alpha 1-AR agonist phenylephrine-stimulated expression of the c-fos gene.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-9513
pubmed:author
pubmed:issnType
Print
pubmed:volume
268
pubmed:geneSymbol
c-fos
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H1006-14
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:7900855-1-Sarcosine-8-Isoleucine Angiotensin II, pubmed-meshheading:7900855-Amino Acid Sequence, pubmed-meshheading:7900855-Angiotensin II, pubmed-meshheading:7900855-Animals, pubmed-meshheading:7900855-Base Sequence, pubmed-meshheading:7900855-Cells, Cultured, pubmed-meshheading:7900855-DNA Primers, pubmed-meshheading:7900855-Gene Expression, pubmed-meshheading:7900855-Genes, fos, pubmed-meshheading:7900855-Humans, pubmed-meshheading:7900855-Molecular Sequence Data, pubmed-meshheading:7900855-Muscle, Smooth, Vascular, pubmed-meshheading:7900855-Phenoxybenzamine, pubmed-meshheading:7900855-Protein Kinase C, pubmed-meshheading:7900855-RNA, Messenger, pubmed-meshheading:7900855-Rats, pubmed-meshheading:7900855-Receptors, Adrenergic, alpha-1, pubmed-meshheading:7900855-Transcription, Genetic
pubmed:year
1995
pubmed:articleTitle
Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells.
pubmed:affiliation
Department of Medicine, Stanford University School of Medicine, Palo Alto, California.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.